Myelin degeneration and diminished myelin renewal contribute to age-related deficits in memory
Related Experiment Video
Updated: Dec 28, 2025

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Fei Wang1, Shu-Yu Ren1, Jing-Fei Chen1
1Department of Histology and Embryology, Chongqing Key Laboratory of Neurobiology, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, Third Military Medical University, Chongqing, China.
Abstract:
Cognitive decline remains an unaddressed problem for the elderly. We show that myelination is highly active in young mice and greatly inhibited in aged mice, coinciding with spatial memory deficits. Inhibiting myelination by deletion of Olig2 in oligodendrocyte precursor cells impairs spatial memory in young mice, while enhancing myelination by deleting the muscarinic acetylcholine receptor 1 in oligodendrocyte precursor cells, or promoting oligodendroglial differentiation and myelination via clemastine treatment, rescues spatial memory decline during aging.
Insights
Myelination actively supports spatial memory in young mice but declines with age. Enhancing myelination in aged mice can reverse cognitive decline, offering potential therapeutic strategies for elderly memory loss.
Area of Science:
- Neuroscience
- Aging Research
- Cell Biology
Background:
- Cognitive decline is a significant challenge in aging populations.
- Myelination, the process of forming the myelin sheath around nerve fibers, is crucial for efficient neural communication.
- Reduced myelination has been observed in aged individuals, correlating with cognitive impairments.
Purpose of the Study:
- To investigate the role of myelination in age-related spatial memory deficits.
- To explore potential interventions to enhance myelination and rescue cognitive function in aging.
Main Methods:
- Utilized mouse models with genetic modifications affecting oligodendrocyte precursor cells (OPCs).
- Assessed spatial memory performance using behavioral tests.
- Investigated the effects of pharmacological agents (clemastine) on myelination and cognition.
Main Results:
- Myelination is robust in young mice and significantly reduced in aged mice, paralleling spatial memory decline.
- Inhibiting myelination in young mice via Olig2 deletion impaired spatial memory.
- Enhancing myelination by deleting muscarinic acetylcholine receptor 1 in OPCs or through clemastine treatment rescued age-related memory deficits.
Conclusions:
- Myelination levels directly impact spatial memory function across the lifespan.
- Oligodendroglial function and myelination are critical targets for mitigating age-related cognitive decline.
- Pharmacological enhancement of myelination shows promise for treating memory loss in the elderly.
Related Concept Videos
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Interference and Decay
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
Higher Mental Functions of Brain: Learning and Memory

